
    
      To assess the toxicity associated with vaccination of melanoma patients with dendritic cell
      (DC)/tumor fusions. To determine if cellular and humoral immunity can be induced by serial
      vaccination with DC/tumor fusions cells. To determine if vaccination DC/tumor fusions results
      in a tumor response.
    
  